Phosphorylation of β-d-Ribosylbenzimidazoles Is Not Required for Activity against Human Cytomegalovirus

We have previously reported that 2,5,6-trichloro-1-(β-d-ribofuranosyl)benzimidazole (TCRB) and its 2-bromo analog (2-bromo-5,6-dichloro-1-(β-d-ribofuranosy)benzimidazole [BDCRB]) are potent and selective inhibitors of human cytomegalovirus (HCMV) replication that block viral DNA maturation via HCMV...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Krosky, Paula M., Borysko, Katherine Z., Nassiri, M. Reza, Devivar, Rodrigo V., Ptak, Roger G., Davis, Michelle G., Biron, Karen K., Townsend, Leroy B., Drach, John C.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2002
Sujets:	Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127035/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11796361/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.2.478-486.2002
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!